12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Belviq lorcaserin regulatory update

Arena said partner Eisai submitted an MAA to Mexico's Federal Commission for the Protection Against Sanitary Risks (COFEPRIS) for obesity drug Belviq lorcaserin. Eisai is seeking approval of Belviq for use in adults with...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >